Modified human C3 DNA sequences and vectors
US6221657A · kind A · utility
6Cited by
2References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 11, 1998 |
| Grant date | Apr 24, 2001 |
| Priority date | — |
| Expiry date | Aug 11, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/472
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
This invention is directed to DNA sequences encoding narrative complement pathway proteins modified such that the protein is capable of forming a stable C3 convertase. The modified C3 proteins are useful in therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.